GlassScriptPhysician profile
Krishna M Namburi
NPI 1942319934
$73,480.74
in general payments reported to CMS, 2019-2025
41 companies · $2,744 in 2025
The $2,744 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,485 · 2021: $14K · 2022: $16K · 2023: $13K · 2024: $9,728 · 2025: $2,744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $6,928 · Travel and Lodging: $676 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,905.00 |
| Food and Beverage | $6,928.24 |
| Travel and Lodging | $675.91 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $60,996.48 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $2,504.93 | 2019-2025 | General - Therapies, Avvigo Guidance System, Watchman Flx |
| Abbott Laboratories | $1,818.45 | 2019-2025 | Cardiomems, Mitraclip, Gallant |
| Novartis Pharmaceuticals Corporation | $1,123.34 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $818.71 | 2019-2024 | Brilinta, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $725.62 | 2019-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $576.89 | 2023-2025 | Symplicity G3, Onyx Frontier, Ffrangio |
| Merck Sharp & Dohme LLC | $544.72 | 2022-2025 | Verquvo, Lagevrio |
| Amgen INC. | $497.22 | 2019-2024 | Repatha |
| Pfizer INC. | $404.43 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $364.70 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $313.49 | 2019-2024 | |
| Amarin Pharma, INC. | $306.33 | 2020-2021 | |
| Novo Nordisk INC | $283.56 | 2019-2025 | Ozempic, Wegovy |
| Edwards Lifesciences Corporation | $235.98 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $197.64 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.09 | 2019 | |
| Shockwave Medical, INC | $185.25 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $183.83 | 2023-2025 | Opsumit, Uptravi, Opsynvi |
| Philips North America LLC | $163.61 | 2019-2024 | (9520) Igt Devices Undivided |
| Cardiovascular Systems INC. | $146.27 | 2022 | |
| Endologix LLC | $145.37 | 2021 | |
| Chiesi USA, INC. | $108.68 | 2019-2021 | |
| Astellas Pharma US INC | $89.99 | 2019 | |
| Baxter Healthcare | $77.87 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Cardinal Health 200 LLC | $61.21 | 2019 | |
| Biotronik INC. | $48.86 | 2024-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Penumbra, INC. | $43.36 | 2025 | Indigo System, Penumbra System |
| Medtronic Vascular, INC. | $39.45 | 2019 | |
| United Therapeutics Corporation | $35.70 | 2024 | Tyvaso |
| Cordis US Corp. | $33.48 | 2024-2025 | Saber, Mynx Control Venous |
| Regeneron Healthcare Solutions, INC. | $30.64 | 2019-2022 | |
| Scpharmaceuticals INC. | $29.73 | 2023 | |
| Acist Medical Systems, INC. | $27.80 | 2023 | |
| Gilead Sciences, INC. | $25.78 | 2019 | |
| Teleflex LLC | $20.21 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.09 | 2024 | Arcalyst |
| Abiomed | $16.99 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $16.85 | 2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $16.83 | 2025 | Assure Wcd |
| Lundbeck LLC | $15.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Namburi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.